Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients

被引:24
|
作者
Jiang, Binghu [1 ]
Wang, Xiaoyun [2 ]
Yao, Zhiyong [3 ]
Wu, Hongfei [4 ]
Xiao, Leijuan [2 ]
Gong, Hai [3 ]
Gao, Zhanhui [2 ]
机构
[1] North Sichuan Med Coll, Clin Med Coll 2, Nanchong Cent Hosp, Dept Radiol, Nanchong, Peoples R China
[2] Nanjing Med Univ, Affiliated BenQ Hosp, BenQ Med Ctr, Dept Nephrol, 71 Hexi St, Nanjing 210019, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated BenQ Hosp, BenQ Med Ctr, Dept Ultrasonog, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Affiliated BenQ Hosp, BenQ Med Ctr, Dept Urol, Nanjing, Jiangsu, Peoples R China
基金
中国博士后科学基金;
关键词
secondary hyperparathyroidism; maintenance hemodialysis; parathyroidectomy; microwave ablation; CHRONIC KIDNEY-DISEASE; OUTCOMES;
D O I
10.1111/hdi.12740
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Secondary hyperparathyroidism (SHPT) is a serious and common problem in patients undergoing maintenance hemodialysis. Minimally invasive microwave ablation (MWA) has been used to treat SHPT and shows some advantages. However, its efficacy is still undefined. The primary purpose of this study was to determine the efficacy and safety of MWA compared to total parathyroidectomy plus forearm autotransplantation. Methods: The SHPT patients who were undergoing maintenance hemodialysis (follow-up for 6 to 24months after treatments) were divided into a MWA group (n=33) and a parathyroidectomy group (n=48). The efficacy (serum intact parathyroid hormone [iPTH], calcium, and phosphorus levels) and safety (hoarseness, hypocalcaemia, and persistently low iPTH) were compared between the two groups. Additionally, the study explored potential predictors of response to MWA by a logistic regression analysis. Findings: There were no significant differences in baseline characteristics between the two groups. The rates of achieving the recommended goal for iPTH were significantly higher in the MWA group than that in the parathyroidectomy group at all follow-up times: 57.58% vs. 12.50% at one-day (P <0.001), 45.45% vs. 16.67% at 1-week (P=0.005), 57.58% vs. 16.67% at 2-week (P <0.001), 57.58% vs. 22.92% at 1-month (P=0.002), and 69.70% vs. 35.42% at 3-month (P=0.002), 76.47% vs. 28.57% at 6-month (P=0.005), 87.50% vs. 47.37% at 12-month (P=0.008), and 81.82% vs. 52.63% at 24-month (P=0.015), respectively. However, there were no significant differences for phosphorus or calcium at any of the follow-up times (P >0.05). The persistently low iPTH was more in the parathyroidectomy group (64.6%) than that in the MWA group (0%) (P <0.001), but there was no significant difference in hoarseness or hypocalcaemia (P >0.05). Baseline levels of iPTH (P=0.021) and patient age (P=0.011) were determined as predictors by univariate logistic regression analysis. Conclusion: The MWA could be an alternative to parathyroidectomy for SHPT but its eventual superiority has to be demonstrated by a proper study.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [21] Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism
    Moldovan, Diana
    Racasan, Simona
    Kacso, Ina Maria
    Rusu, Crina
    Potra, Alina
    Bondor, Cosmina
    Patiu, Ioan Mihai
    Gherman-Caprioara, Mirela
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (11) : 1871 - 1877
  • [22] Safety of parathyroidectomy in older vs. younger patients with primary hyperparathyroidism
    Mueller, Marlena
    Ebrahimi, Fahim
    Christ, Emanuel
    Nebiker, Christian Andreas
    Schuetz, Philipp
    Mueller, Beat
    Kutz, Alexander
    ENDOCRINE CONNECTIONS, 2021, 10 (10) : 1273 - 1282
  • [23] Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis
    Diao, Zongli
    Wang, Liyan
    Li, Dishan
    Liu, Wenhu
    RENAL FAILURE, 2017, 39 (01) : 140 - 145
  • [24] Effect of sodium zirconium cyclosilicate on hyperkalemia after parathyroidectomy in secondary hyperparathyroidism patients with maintenance hemodialysis: A randomized trial
    Kang, Jing
    Li, Sijia
    Su, Jinglin
    Xiao, Zhixue
    Zhang, Siyi
    Liu, Shuangxin
    Ge, Pingjiang
    MEDICINE, 2024, 103 (52)
  • [25] PARATHYROIDECTOMY FOR HYPERPARATHYROIDISM IN MAINTENANCE DIALYSIS PATIENTS
    HEAF, JG
    TRANEBJAERG, L
    WOLF, H
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1983, 17 (03): : 347 - 353
  • [26] Impacts of parathyroidectomy on renal anemia and nutritional status of hemodialysis patients with secondary hyperparathyroidism
    Chen, Chen
    Wu, Hua
    Zhong, Lin
    Wang, Xin
    Xing, Zhuang-Jie
    Gao, Bi-Hu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 9830 - 9838
  • [27] Impact of parathyroidectomy on the morphology and the number of osteocyte in hemodialysis patients with secondary hyperparathyroidism.
    Yajima, A
    Takahashi, HE
    Ogawa, Y
    Inou, T
    Otsubo, O
    Yagi, S
    Otsubo, K
    Tominaga, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S424 - S425
  • [28] SUBTOTAL PARATHYROIDECTOMY IN TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN 12 CHRONIC-HEMODIALYSIS PATIENTS
    FUJITA, T
    ASANO, H
    KINUKAWA, T
    ONO, Y
    OHSHIMA, S
    IMAGAWA, T
    AMANO, I
    SUGIYAMA, S
    TOMITA, A
    JAPANESE JOURNAL OF UROLOGY, 1981, 72 (01): : 98 - 107
  • [29] Efficacy of Paricalcitol in the Treatment of Secondary Hyperparathyroidism in Maintenance Hemodialysis Patients
    Ou, Santao
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 920 - 920
  • [30] THE ROLE OF PARATHYROIDECTOMY IN THE MANAGEMENT OF HYPERPARATHYROIDISM IN PATIENTS ON MAINTENANCE HEMODIALYSIS AND AFTER RENAL-TRANSPLANTATION
    MEMMOS, DE
    WILLIAMS, GB
    EASTWOOD, JB
    GORDON, EM
    COCHRANE, CL
    GOWER, PE
    CURTIS, JR
    PHILLIPS, ME
    RAINFORD, DJ
    DEWARDENER, HE
    NEPHRON, 1982, 30 (02) : 143 - 148